Drug intelligence / Profile preview

Elimax

Development stage
Unknown
Lead developer
Oystershell
Modality
Small Molecules
Administration
Topical
01

Overview

Elimax is an over-the-counter, non-neurotoxic pediculicide line used to treat and prevent head lice (Pediculus humanus capitis) infestations and their eggs (nits). The products (shampoos and lotions) use specially developed polymer or oligodecene/bio-alkane oils, sometimes combined with beeswax, to exert a purely physical mechanism: they suffocate lice by blocking their respiratory spiracles and dehydrate both lice and nits by disrupting the protective lipid layer of the cuticle, thereby killing all life stages without conventional insecticides or dimethicone.[5][6][13][17] The formulations also incorporate a patented LPF complex of polymers and lipophilic substances that reduces hair’s static charge, makes hair surfaces difficult for lice to grasp, and acts as a repellant, providing short-term protection against reinfestation.[5][6][15][17] Elimax is developed and marketed by Oystershell as a consumer health product and is sold in multiple European and international markets for the management and prophylaxis of head lice infestations in children and adults.[2][4][12][14]

Brand names
Elimax

Beyond the preview

Go deeper on Elimax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elimax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call